Tradestie Institutional Equity Comparison Engine

LMRI vs XZO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

XZO Overall Edge

XZO Captures Institutional Edge (2โ€“1 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Exzeo Group, Inc. (XZO) driven by superior Valuation, Growth & Margin while LMRI counters with relative strength in Momentum & Technical. Fundamentally, LMRI trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus XZO at 12.5x Forward P/E and 50.4% operating margin (+4.0% YoY). In options structure, LMRI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against XZO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner XZO
LMRI N/M vs XZO 12.5x Fwd P/E
Growth & Margin Winner XZO
Op Margin N/A vs 50.4% ยท YoY N/A vs +4.0%
Momentum & Technical Winner LMRI
1Y -23.0% vs +0.9% ยท 52W Pos 60% vs 19%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
LMRI US Equity
LMRI
Institutional Equity
$14.26
+1.42% 1D
Market Cap N/A
1M Return +30.95%
1Y Return -23.0%
Forward P/E N/M
Unified AI Score
32.1 / 100 SELL
Tech 50.0 Fund 30.0 Flow 50.0 Mom 50.0
XZO US Equity
Exzeo Group, Inc.
Services-Prepackaged Software
$14.72
-3.03% 1D
Market Cap $1.4B
1M Return -13.41%
1Y Return +0.89%
Forward P/E 12.5x
Unified AI Score
47.7 / 100 HOLD
Tech 39.0 Fund 50.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: LMRI -23.0% XZO +0.89% Spread: +3.18 pp (LMRI Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
LMRI TTM Op. Margin: N/A XZO TTM Op. Margin: 50.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on LMRI vs XZO. Trailing 12-month operating profitability (LMRI N/A vs XZO 50.4%) and valuation multiples (LMRI N/M vs XZO 12.5x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: LMRI (1) vs XZO (9)
Institutional Metric LMRI XZO Criterion Row Winner
Market Capitalization Scale N/A $1.4B Larger Scale XZO
Trailing P/E Ratio Valuation N/M 15.5x Lower Multiple XZO
Forward P/E Ratio Valuation N/M 12.5x Lower Multiple XZO
Revenue Growth (YoY) Growth N/A +4.0% Higher Growth XZO
Operating Margin (TTM) Profitability N/A 50.4% Higher Margin XZO
Net Profit Margin Profitability N/A 37.8% Higher Margin XZO
Return on Equity (ROE) Capital Efficiency N/A 46.7% Higher ROE XZO
52-Week Range Position Momentum 60% ($6โ€“$19) 19% ($12โ€“$25) Stronger Trend LMRI
Beta / 30D Volatility Risk Regime 1.22ฮฒ ยท 85% Vol 1.08ฮฒ ยท 60% Vol Lower Realized Risk XZO
Unified Institutional Score Composite Signal 32.1 / 100 (SELL) 47.7 / 100 (HOLD) Higher Composite XZO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full LMRI vs XZO Buy Guide
LMRI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live LMRI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
XZO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live XZO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither LMRI nor XZO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.